NurExone Biologic Inc.: NurExone Reports Second Quarter 2022 Financial Results and Provides Business Update

Calgary, Alberta--(Newsfile Corp. - August 25, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided

Related Keywords

New York ,United States ,Canada ,United Kingdom ,Toronto ,Ontario ,Israel ,Singapore ,Vancouver ,British Columbia ,Canadian ,James Jay Richardson ,Canaccord Genuity ,Lior Shaltiel ,Oded Orgil ,Jay Richardson ,Clarkson Gordon Arthur Young ,Advisory Services ,Twitter ,Enerspar Corp The Company Or Nurexone ,Polyrizon Ltd ,Royal Canadian Academy Mr ,Canada Israel Chamber ,Insolvency Practitioner Association Of The United Kingdom ,Nurexone Biologic Inc ,Facebook ,York University ,Alberta Newsfile Corp ,Venture Exchange ,Medigus Ltd ,Merrill Lynch ,Targus Corporation ,Drug Administration ,University Of Western Ontario ,Adcore Inc ,Technion University ,Youtube ,Ernst Young ,Israel Institute Of Technology ,Manulife Financial ,Research Agreement ,Exone Biologic ,Enerspar Corp ,Chemistry Manufacturing ,Pre Investigational New Drug ,Intellectual Property ,Spinal Cord Injury ,Reverse Takeover Transaction ,Extracellular Vesicles ,Central Nervous System ,Patent Cooperation Treaty ,Sponsor Research Agreement ,Collaboration Agreement ,Canadian Chartered Accountant ,Singapore Certified Public Accountant ,Insolvency Practitioner Association ,Interim Chairman ,Royal Canadian Academy ,Capital Markets ,Financial Advisor ,Senior Executive ,Gravitas Securities ,San Jose ,Bay Street ,Western Ontario ,Political Science ,Quarter Fiscal ,Services Shares ,Israel Institute ,Executive Officer ,Nurexone ,Biologic ,Reports ,Second ,Quarter ,022 ,Financial ,Results ,Rovides ,Business ,Update ,